{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T14:49:03Z","timestamp":1769352543795,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"A. P. M\u00f8ller Foundation for the Advancement of Medical Science","award":["11377"],"award-info":[{"award-number":["11377"]}]},{"DOI":"10.13039\/501100008249","name":"Frimodt-Heineke Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008249","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002739","name":"Aarhus University Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002739","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Danish Council for Independent Research | Medical Sciences","award":["0602-01706B"],"award-info":[{"award-number":["0602-01706B"]}]}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.bone.2014.06.020","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T01:31:23Z","timestamp":1403573483000},"page":"287-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Additive effect of PTH (1\u201334) and zoledronate in the prevention of disuse osteopenia in rats"],"prefix":"10.1016","volume":"66","author":[{"given":"Jens Bay","family":"Vegger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esben Sommer","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4833-0888","authenticated-orcid":false,"given":"Annemarie","family":"Br\u00fcel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper Skovhus","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2014.06.020_bb0005","first-page":"915","article-title":"Cancellous bone structure of iliac crest biopsies following 370days of head-down bed rest","volume":"76","author":"Thomsen","year":"2005","journal-title":"Aviat Space Environ Med"},{"key":"10.1016\/j.bone.2014.06.020_bb0010","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/0026-0495(89)90226-6","article-title":"Effects of a bisphosphonate (1-hydroxy ethylidene-1,1 bisphosphonic acid) on osteoclast number during prolonged bed rest in healthy humans","volume":"38","author":"Chappard","year":"1989","journal-title":"Metabolism"},{"key":"10.1016\/j.bone.2014.06.020_bb0015","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/cs0640537","article-title":"Vertebral bone loss: an unheeded side effect of therapeutic bed rest","volume":"64","author":"Kr\u00f8lner","year":"1983","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.bone.2014.06.020_bb0020","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1359\/jbmr.1999.14.8.1394","article-title":"Age- and gender-related differences in vertebral bone mass, density, and strength","volume":"14","author":"Ebbesen","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.06.020_bb0025","first-page":"383","article-title":"Effects of a 120day period of bed-rest on bone mass and bone cell activities in man: attempts at countermeasure","volume":"2","author":"Vico","year":"1987","journal-title":"Bone Miner"},{"key":"10.1016\/j.bone.2014.06.020_bb0030","doi-asserted-by":"crossref","first-page":"A23","DOI":"10.3357\/ASEM.BR02.2009","article-title":"Skeletal effects of long-duration head-down bed rest","volume":"80","author":"Spector","year":"2009","journal-title":"Aviat Space Environ Med"},{"key":"10.1016\/j.bone.2014.06.020_bb0035","series-title":"From space to Earth: advances in human physiology from 20years of bed rest studies (1986\u20132006)","author":"Pavy-Le Traon","year":"2007"},{"key":"10.1016\/j.bone.2014.06.020_bb0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bone.2010.09.009","article-title":"Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model","volume":"48","author":"Tian","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/8756-3282(96)00112-3","article-title":"Time responses of cancellous and cortical bones to sciatic neurectomy in growing female rats","volume":"19","author":"Zeng","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0050","first-page":"S23","article-title":"A new rat model simulating some aspects of space flight","volume":"22","author":"Morey","year":"1979","journal-title":"Physiologist"},{"key":"10.1016\/j.bone.2014.06.020_bb0055","first-page":"250","article-title":"Bone atrophy: an experimental and clinical study of the changes in bone which result from non-use","volume":"33","author":"Allison","year":"1921","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.bone.2014.06.020_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/8756-3282(92)90356-2","article-title":"Prostaglandin E2 prevents bone loss and adds extra bone to immobilized distal femoral metaphysis in female rats","volume":"13","author":"Akamine","year":"1992","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S8756-3282(00)00438-5","article-title":"Texture analysis of X-ray radiographs is a more reliable descriptor of bone loss than mineral content in a rat model of localized disuse induced by the Clostridium botulinum toxin","volume":"28","author":"Chappard","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molmed.2005.06.012","article-title":"New insights into clostridial neurotoxin\u2013SNARE interactions","volume":"11","author":"Breidenbach","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.bone.2014.06.020_bb0075","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1007\/s00018-008-8088-0","article-title":"Highly specific interactions between botulinum neurotoxins and synaptic vesicle proteins","volume":"65","author":"Brunger","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bone.2014.06.020_bb0080","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00223-012-9576-7","article-title":"Loss of bone strength is dependent on skeletal site in disuse osteoporosis in rats","volume":"90","author":"Thomsen","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2014.06.020_bb0085","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2014.06.020_bb0090","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2014.06.020_bb0095","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","article-title":"Molecular and cellular mechanisms of the anabolic effect of intermittent PTH","volume":"40","author":"Jilka","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0100","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","article-title":"Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone","volume":"104","author":"Jilka","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2014.06.020_bb0105","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/endo.136.8.7628403","article-title":"Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells","volume":"136","author":"Dobnig","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2014.06.020_bb0110","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/jbmr.1665","article-title":"Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts","volume":"27","author":"Kim","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.06.020_bb0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/00365513.2011.624631","article-title":"Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans","volume":"72","author":"Aslan","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.bone.2014.06.020_bb0120","first-page":"53","article-title":"PTH and interactions with bisphosphonates","volume":"1","author":"Gasser","year":"2000","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.bone.2014.06.020_bb0125","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.bone.2011.02.007","article-title":"Ibandronate does not reduce the anabolic effects of PTH in ovariectomized rat tibiae: a microarchitectural and mechanical study","volume":"48","author":"Yang","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/8756-3282(95)00115-T","article-title":"Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats","volume":"16","author":"Li","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0135","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.stem.2010.09.012","article-title":"Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling","volume":"7","author":"Wu","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bone.2014.06.020_bb0140","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.bone.2008.05.010","article-title":"The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice","volume":"44","author":"Yamane","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0145","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2014.06.020_bb0150","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1210\/jc.2009-1703","article-title":"Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis","volume":"95","author":"Finkelstein","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.06.020_bb0155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/jbmr.238","article-title":"Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1\u201334)] in postmenopausal osteoporosis","volume":"26","author":"Cosman","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.06.020_bb0160","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bone.2005.08.009","article-title":"Botox induced muscle paralysis rapidly degrades bone","volume":"38","author":"Warner","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0165","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.06.020_bb0170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2818.2005.01469.x","article-title":"Stereological measures of trabecular bone structure: comparison of 3D micro computed tomography with 2D histological sections in human proximal tibial bone biopsies","volume":"218","author":"Thomsen","year":"2005","journal-title":"J Microsc"},{"key":"10.1016\/j.bone.2014.06.020_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bone.2012.11.037","article-title":"PTH (1\u201334), but not strontium ranelate counteract loss of trabecular thickness and bone strength in disuse osteopenic rats","volume":"53","author":"Br\u00fcel","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0180","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/jbmr.5650100322","article-title":"Human parathyroid hormone-(1\u201338) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats","volume":"10","author":"Ma","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.06.020_bb0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1359\/jbmr.061006","article-title":"Dose\u2013response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats","volume":"22","author":"Turner","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.06.020_bb0190","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.pmrj.2013.03.032","article-title":"Effect of parathyroid hormone combined with gait training on bone density and bone architecture in people with chronic spinal cord injury","volume":"5","author":"Gordon","year":"2013","journal-title":"PM R"},{"key":"10.1016\/j.bone.2014.06.020_bb0195","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1210\/en.2010-1112","article-title":"Teriparatide [rhPTH (1\u201334)], but not strontium ranelate, demonstrated bone anabolic efficacy in mature, osteopenic, ovariectomized rats","volume":"152","author":"Ma","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2014.06.020_bb0200","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10735-007-9096-3","article-title":"Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone","volume":"38","author":"Silvestrini","year":"2007","journal-title":"J Mol Histol"},{"key":"10.1016\/j.bone.2014.06.020_bb0205","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s007760200063","article-title":"Comparative effects of intermittent administration of human parathyroid hormone (1\u201334) on cancellous and cortical bone loss in tail-suspended and sciatic neurectomized young rats","volume":"7","author":"Moriyama","year":"2002","journal-title":"J Orthop Sci"},{"key":"10.1016\/j.bone.2014.06.020_bb0210","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1210\/endo.139.10.6227","article-title":"Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats","volume":"139","author":"Turner","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2014.06.020_bb0215","doi-asserted-by":"crossref","first-page":"33086","DOI":"10.1074\/jbc.M705194200","article-title":"Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis","volume":"282","author":"Li","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2014.06.020_bb0220","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00198-009-1082-z","article-title":"Detecting early bone changes using in vivo micro-CT in ovariectomized, zoledronic acid-treated, and sham-operated rats","volume":"21","author":"Perilli","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2014.06.020_bb0225","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bone.2007.06.021","article-title":"The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength","volume":"41","author":"Yao","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0230","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00223-008-9160-3","article-title":"Influence of early and late zoledronic acid administration on vertebral structure and strength in ovariectomized rats","volume":"83","author":"Brouwers","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2014.06.020_bb0235","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1152\/japplphysiol.00632.2007","article-title":"Development of a low-dose anti-resorptive drug regimen reveals synergistic suppression of bone formation when coupled with disuse","volume":"104","author":"Lloyd","year":"2008","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.bone.2014.06.020_bb0240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00198-010-1221-6","article-title":"Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury","volume":"22","author":"Bubbear","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2014.06.020_bb0245","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00223-007-9012-6","article-title":"Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury","volume":"80","author":"Shapiro","year":"2007","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2014.06.020_bb0250","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2010.10.159","article-title":"Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know","volume":"49","author":"Allen","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0169-6009(90)90046-I","article-title":"Consequences of the remodelling process for vertebral trabecular bone structure: a scanning electron microscopy study (uncoupling of unloaded structures)","volume":"10","author":"Mosekilde","year":"1990","journal-title":"Bone Miner"},{"key":"10.1016\/j.bone.2014.06.020_bb0260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2014.01.008","article-title":"A closer look at the immediate trabecula response to combined parathyroid hormone and alendronate treatment","volume":"61","author":"Altman","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0265","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bone.2012.09.039","article-title":"Positive alterations of viscoelastic and geometric properties in ovariectomized rat femurs with concurrent administration of ibandronate and PTH","volume":"52","author":"Yang","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0270","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bone.2014.06.020_bb0275","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/8756-3282(95)00113-R","article-title":"The anabolic effect of human PTH (1\u201334) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate\u2014is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?","volume":"16","author":"Delmas","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0280","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.bone.2007.07.005","article-title":"Risedronate did not block the maximal anabolic effect of PTH in aged rats","volume":"41","author":"Yao","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.020_bb0285","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00223-012-9570-0","article-title":"Bisphosphonate binding affinity affects drug distribution in both intracortical and trabecular bone of rabbits","volume":"90","author":"Turek","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2014.06.020_bb0290","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.2174\/138161210793563635","article-title":"Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages","volume":"16","author":"Roelofs","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bone.2014.06.020_bb0295","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1359\/JBMR.051109","article-title":"A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide","volume":"21","author":"Lindsay","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.06.020_bb0300","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1359\/JBMR.050309","article-title":"Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters","volume":"20","author":"Arlot","year":"2005","journal-title":"J Bone Miner Res"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214002294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214002294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T01:13:10Z","timestamp":1589245990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328214002294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":60,"alternative-id":["S8756328214002294"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2014.06.020","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Additive effect of PTH (1\u201334) and zoledronate in the prevention of disuse osteopenia in rats","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2014.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}